STAT+: AbbVie to buy Apogee Therapeutics in nearly $11B deal

🇺🇸 STAT News Health (US) —
STAT+: AbbVie to buy Apogee Therapeutics in nearly $11B deal

AI Summary

AbbVie is set to acquire Apogee Therapeutics, a company developing an experimental drug for atopic dermatitis, for nearly $11 billion. This deal underscores continued acquisition activity in the pharmaceutical sector.

AbbVie is buying Apogee Therapeutics, the developer of an experimental atopic dermatitis drug, for nearly $11B, continuing a run of pharma acquisitions.

Markets Deals Health pharmaceutical acquisition AbbVie Apogee Therapeutics atopic dermatitis drug biotech deal healthcare markets

Read original source →